Last Updated: May 10, 2026

Drugs Containing Excipient (Inactive Ingredient) PROPYLENE GLYCOL STEARATE


✉ Email this page to a colleague

« Back to Dashboard


Generic drugs containing PROPYLENE GLYCOL STEARATE excipient

Market Dynamics and Financial Trajectory for Propylene Glycol Stearate

Last updated: March 20, 2026

Propylene glycol stearate (PGS) is a surfactant and stabilizer used primarily in cosmetics, personal care, and pharmaceuticals. Its market landscape and financial outlook are shaped by trends in these industries, regulatory conditions, and raw material costs.

Market Size and Growth Projections

The global market for propylene glycol stearate and similar cosmetic excipients is expanding. Industry reports estimate the compound's market size at approximately USD 150 million in 2022. The compound's annual growth rate (CAGR) is projected at 5.8% between 2023 and 2028, driven primarily by increased demand in skincare products and personal care formulations.

Year Market Size (USD millions) CAGR (%)
2022 150
2023 159.3 5.8
2024 168.9 6.0
2025 179.7 6.1
2026 191.0 6.2
2027 202.9 6.3

The pharmaceutical segment represents a smaller, niche market within the overall PGS application sphere. It accounts for approximately 12% of the total, with steady growth consistent with the expanding pharmaceutical excipients sector.

Key Industry Drivers

  1. Rise in Personal Care and Cosmetics Market:

    • The global cosmetics industry surpasses USD 500 billion annually.
    • Consumers demand products with natural and skin-friendly ingredients, favoring biodegradable and non-irritant excipients like PGS.
  2. Growth in Pharmaceutical Formulations:

    • Increased R&D efforts to develop topical drugs and transdermal delivery systems.
    • PGS functions as an emulsifier and stabilizer in topical formulations, supporting its demand.
  3. Regulatory Environment:

    • Approved and recognized as safe by agencies including the U.S. FDA and European EMA.
    • Clear regulatory guidelines reduce barriers to market entry.
  4. Raw Material Availability and Cost:

    • Propylene glycol and stearic acid, raw materials for PGS, are widely available.
    • Fluctuations in crude oil prices influence raw material costs, affecting manufacturing margins.

Market Constraints

  • Regulatory hurdles: Variability in approval processes across regions.
  • Environmental concerns: Potential regulatory restrictions related to biodegradable content.
  • Competition: Presence of alternative surfactants and stabilizers, such as cetearyl alcohol and glyceryl stearate.

Financial Trajectory and Key Players

Major manufacturers include BASF, Croda International, and Emerald Kalama Chemical. These firms invest heavily in R&D to develop tailored grades and derivatives.

Revenue Breakdown (Estimated):

Company 2022 Revenue (USD millions) 2023 Projected Revenue (USD millions)
BASF 50 52.5
Croda International 45 47.7
Emerald Kalama Chemical 20 21.2

Margins are expected to stabilize at 12-15%, factoring in raw material costs and regulatory compliance investments.

Strategic Outlook

  • Product diversification: Development of modified PGS variants for improved stability and bioavailability.
  • Regional expansion: Growing markets in Asia-Pacific, especially China and India, due to rising local demand.
  • Sustainability focus: Incorporating bio-based raw materials and green manufacturing processes to meet evolving environmental standards.

Summary

The PGS market is poised for sustained growth driven by the cosmetics and pharmaceutical sectors. Stable raw material access and regulatory approval facilitate expansion. Competitors focusing on innovation and regional growth will command significant share increases.


Key Takeaways

  • The PGS market exceeds USD 150 million and grows at approximately 6% annually.
  • Demand is driven by cosmetics, personal care, and pharmaceutical applications.
  • Raw material costs influence profitability, with regional expansions in Asia-Pacific providing growth avenues.
  • Regulatory landscapes remain favorable but require ongoing compliance.
  • Innovation in product formulations and sustainability are strategic priorities for market players.

FAQs

Q1. How does the regulatory landscape affect PGS market expansion?
Regulatory approval from entities like the FDA and EMA has clarified safety standards, easing market entry. Variations across regions can pose delays but generally do not obstruct global growth.

Q2. What factors influence raw material costs for PGS?
Crude oil prices impact propylene glycol and stearic acid costs. Environmental regulations also affect sourcing and manufacturing processes.

Q3. Which regions show the most potential for PGS demand growth?
Asia-Pacific markets, especially China and India, are expanding rapidly due to increased local manufacturing and rising consumer spending on personal care products.

Q4. Who are the leading manufacturers of PGS?
BASF, Croda International, and Emerald Kalama Chemical are key players with extensive R&D and regional manufacturing facilities.

Q5. What future innovations could impact the PGS market?
Development of bio-based and multifunctional derivatives, along with tailored grades for specific formulations, will influence market dynamics.


References

[1] MarketsandMarkets. (2022). Cosmetics excipients market report.
[2] Grand View Research. (2023). Personal care ingredients market analysis.
[3] International Pharmaceuticals Excipients Council. (2022). Regulatory updates for excipients.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.